|
THAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83719706114971E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.86069945509837E-10 |
| Normal-vs-Stage2 |
3.63279999970878E-07 |
| Normal-vs-Stage3 |
9.11926090196857E-12 |
| Normal-vs-Stage4 |
2.01372252206511E-12 |
| Stage1-vs-Stage2 |
6.523000E-01 |
| Stage1-vs-Stage3 |
2.244000E-02 |
| Stage1-vs-Stage4 |
6.777400E-04 |
| Stage2-vs-Stage3 |
2.590400E-01 |
| Stage2-vs-Stage4 |
1.574110E-02 |
| Stage3-vs-Stage4 |
1.350770E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.01203506580805E-13 |
| Normal-vs-AfricanAmerican |
1.69111999999139E-05 |
| Normal-vs-Asian |
1.77980000004574E-06 |
| Caucasian-vs-AfricanAmerican |
9.331400E-01 |
| Caucasian-vs-Asian |
3.818200E-01 |
| AfricanAmerican-vs-Asian |
5.208200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.69926311805102E-13 |
| Normal-vs-Female |
1.50319756642148E-11 |
| Male-vs-Female |
5.212400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.40470004703775E-09 |
| Normal-vs-Age(41-60Yrs) |
7.91344767492319E-12 |
| Normal-vs-Age(61-80Yrs) |
8.38717983953075E-12 |
| Normal-vs-Age(81-100Yrs) |
6.998600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.351970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.092190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.220600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.573800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.402200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.033000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.593800E-02 |
| Classical-VS-Follicular |
8.025000E-01 |
| Classical-VS-Other |
6.665800E-01 |
| Classical-VS-Normal |
7.1901373743799E-12 |
| Tall-VS-Follicular |
3.390200E-02 |
| Tall-VS-Other |
6.844000E-01 |
| Tall-VS-Normal |
2.85219958762184E-10 |
| Follicular-VS-Other |
6.652000E-01 |
| Follicular-VS-Normal |
3.68639999970277E-07 |
| Other-VS-Normal |
6.039600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.66079985506474E-10 |
| Normal-vs-N1 |
2.09779971171997E-11 |
| N0-vs-N1 |
3.002300E-02 |
|
|
